Track topics on Twitter Track topics that are important to you
The global nuclear imaging system and equipment market is estimated to reach $2.2 billion by 2022 and is expected to grow at CAGR of 5.6% during 20162022.
The nuclear imaging system and equipment market is majorly driven by the growing demand of nuclear imaging system in various regions. The key drivers of this market are rising awareness about the early diagnosis of disease, larger accuracy insights of the diseases compared to other diagnostic techniques, increasing cases of chronic diseases such as cardiac, cancer, and neurological disorders, approval of florbetapir to boost the sales of scanners and technological advancements. However, unfavorable reimbursement initiatives is the major restraint which is hindering the growth of the global nuclear imaging system and equipment market. In addition, high costs of the imaging system is also affecting the growth of the market. The global nuclear imaging system and market has large number of opportunities such as rising demand for imaging system procedures, rising expenditure on healthcare and increase in geriatric population.
The global nuclear imaging system and equipment market is segmented on the basis of product type, application, end user and geography. Based on the product type, the nuclear imaging system and equipment market is categorized into positron emission tomography PET, singlephoton emission computed tomography SPECT, and planar scintigraphy systems. Positron emission tomography PET is further segmented into hybrid positron emission tomography hybrid PET, and standalone positron emission tomography standalone PET. Singlephoton emission computed tomography SPECT is also further segmented into hybrid SPECT and standalone SPECT. On the basis of application, the market is segmented into cardiology, oncology, neurology, urology, gastroenterology and others applications which includes thyroid related diseases. Based on the end user, the market is categorized into imaging centers, academic research institute, hospitals and pharma or biotech companies.
The nuclear imaging system and equipment market is dominated by some of the major key players such as AgfaGevaert N.V. , Digirad Corporation, Gamma Medica Inc, Neusoft Medical Systems Co. Ltd., Spectrum Dynamics Ltd, Siemens Healthcare, Naviscan Inc, Cardiarc Ltd, Ge Healthcare, Royal Philips Electronics and many more. Innovation, agreements, collaboration, partnerships and expansion is regarded as the key strategies adopted by the market players to sustain in the global market.
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...